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A B S T R A C T
Aim: Cardiovascular magnetic resonance (CMR) has been increasingly used as an alternative method to
evaluate the severity of aortic stenosis. The aim of our study was to evaluate whether the indirect
measurement of the aortic gradient (Calc-PG), derived from Gorlin’s formula, is a reproducible parameter
for gradient assessment. Then, we evaluated if this parameter is correlated with left ventricular
hypertrophy, considered as a marker of severity of aortic stenosis, better than phase-contrast sequences-
derived pressure gradient (PC-PG) and aortic valve area.
Methods: Forty-one patients with isolated aortic stenosis underwent CMR. Calc-PG was obtained from
the formula (cardiac output/aortic valve area)2, and it was compared to PC-PG.
Results: We found that the Calc-PG has higher correlation with left ventricle mass than PC-PG (r2 0.44,
p < 0.001 vs. r2 0.26, p < 0.01), also after multivariate analysis adjusting for age, gender and
hypertension (p < 0.001). Furthermore, Calc-PG was more reproducible than PC-PG. The receiver
operating characteristic comparison curve analysis showed that Calc-PG has a signiﬁcantly higher ability
to describe the presence of left ventricular hypertrophy than PC-PG (area under the curve 0.85, 95% CI
0.70–0.94, p < 0.0001 vs. 0.74, 95% CI 0.58–0.87, p = 0.03).
Conclusions: We propose that transaortic gradient indirectly calculated by using the simpliﬁed Gorlin’s
equation could be an alternative method to assess the severity of aortic stenosis.
 2014 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.
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Aortic stenosis is the most common valvular heart disease [1].
The 2006 American College of Cardiology/American Heart Associ-
ation guidelines for the management of valvular heart diseases
recommend assessing the severity of aortic stenosis by using both
anatomical and hemodynamic parameters, namely the aortic valve
area and the transaortic gradient, respectively [2]. However, recent* Corresponding author at: Advanced Cardiovascular Imaging, 170 East 77th
Street, New York, NY 10075, USA. Tel.: +1 212 369 9200; fax: +1 212 369 5048.
E-mail addresses: valevale2012@hotmail.com, v.valenti80@yahoo.it (V. Valenti).
http://dx.doi.org/10.1016/j.jjcc.2014.07.015
0914-5087/ 2014 Japanese College of Cardiology. Published by Elsevier Ltd. All rightsevidence suggests that the evaluation of the transaortic gradient
might be more accurate to distinguish subjects with moderate or
severe aortic stenosis [3–5].
Cardiovascular magnetic resonance (CMR) has been increas-
ingly used as an alternative method to echocardiography to
evaluate the severity of aortic stenosis [6–8]. Echocardiography
generally provides reliable measurement of pressure gradient.
However, a proper visualization of aortic valve and an accurate
estimation of pressure gradient by echocardiographic examination
can be difﬁcult in some patients with poor acoustic windows, such
as obese subjects, subjects affected by chronic obstructive
pulmonary disease, or in patients who underwent major cardiac
surgery. In addition, an accurate estimation of pressure gradient by reserved.
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sonographer [9,10]. With CMR, evaluation of the aortic valve area
with steady-state-free-precession sequence has been demonstrat-
ed to be highly reliable and reproducible [8,11,12]. On the other
hand, the assessment of aortic ﬂows and aortic pressure gradient
by using the phase-contrast sequences-derived pressure gradient
(PC-PG) is subject to several potential sources of error that may
compromise the correct classiﬁcation of the severity of aortic
stenosis and, subsequently, the clinical management of these
patients [13].
Here we tested the ability of an additional non-invasive
parameter, beyond PC-PG and aortic valve area, for estimating
pressure gradient in aortic stenosis by using CMR. It consists of the
indirect calculation of the gradient from the cardiac output and
aortic valve area, by using the inverse simpliﬁed Gorlin’s formula
[14,15]. A potential advantage of this method is that it can be used
to determine the transvalvular pressure gradient without the
acquisition or analysis of phase contrast images.
Left ventricular (LV) hypertrophy represents the main marker of
preclinical organ damage in patients with aortic stenosis. Previous
studies indicated that LV hypertrophy represents a valid surrogate
marker of the severity of the disease, and remarkably, it is an
accurate and strong predictor for the occurrence of major adverse
events in subjects affected by aortic stenosis [16,17].
The aim of our study was to evaluate whether the above-
mentioned parameter (hereafter Calc-PG) based on the formula,
(cardiac output/aortic valve area)2, is an easy and reproducible
index for the evaluation of pressure gradient. In addition, we tested
whether this parameter is correlated with LV hypertrophy,
considered as a marker of cardiac remodeling caused by aortic
stenosis and as a marker of the severity of the disease, better than
PC-PG and aortic valve area.
Methods
This study is a retrospective analysis of patients referred for a
clinical CMR evaluation in our center. Inclusion criteria included at
least moderate aortic stenosis, as indicated by aortic valve area,
and preserved ejection fraction (LV ejection fraction >50% and
right ventricular ejection fraction >40%). Exclusion criteria
included regional ventricular wall motion abnormalities, other
signiﬁcant associated valve disease, myocardial ischemia or scar,
intra-cardiac shunt, and patients with an irregular cardiac rhythm.
We collected a total of 99 patients with aortic stenosis, who
underwent CMR study. From these we excluded 58 patients due toFig. 1. The aortic localizer view (A) showing a turbulent aortic stenthe presence of atrial ﬁbrillation, concomitant presence of other
valve diseases, myocardial ﬁbrosis detected by contrast delay
analysis, segmental anomalous wall motion, or global LV
dysfunction. The remaining 41 patients represent our study
population. We used the same protocol as in our previous
published papers for the evaluation of transvalvular ﬂow by
CMR [18,19].
Patients were imaged with a 1.5-T MRI scanner using a 8
elements, phased-array cardiac coil (GE Signa, EXCITE, GE Medical
Systems, Milwaukee, WI, USA). Imaging was electrocardiogram-
gated, and performed during breath holds. After scout images
acquisition, short- and long-axis cine images were acquired using
a steady-state free precession pulse sequence (FIESTA) with the
following parameters: repetition time (TR) was 3.5 ms; echo time
(TE) was 1.5 ms; the ﬂip angle was 608; views per segment (VPS)
were 12; ﬁeld of view (FOV) was 350 mm  350 mm; matrix size
was 192  160; nominal temporal resolution was 42 ms; breath
hold time range was 12–20 s; slice thickness was 8.0 mm, and
nominal spatial resolution (voxel size) was 8 mm 
1.8 mm  2.2 mm. With regard to velocity-encoded phase con-
trast imaging, a cine localizer was obtained parallel to the
direction of ﬂow in order to ensure that measurements of velocity
were perpendicular to the plane of ﬂow (Fig. 1A). From this
localizer, PC images were acquired in an imaging plane
perpendicular to the jet, from the LV outﬂow tract through the
tips of the aortic valve cusps. Typically, 6–9 contiguous slices were
acquired, each 4 mm thick, extending 16–24 mm proximal to the
aortic cusp tips and 4–12 mm distal (Fig. 1B). Valve 0 mm
corresponds to the reference plane at the level of tips of the open
aortic cusps, whereas valve 24 mm and valve +12 mm are
located 24 mm and 12 mm proximal to and distal to this reference,
respectively. We used the following nominal scan parameters: TR
was 6.5 ms; TE was 3.8 ms; the ﬂip angle was 208; VPS was 6; FOV
was 480 mm  360 mm; matrix size was 512  224; nominal
temporal resolution was 78 ms; breath hold time range was
18–30 s; maximum encoded velocity (VENCmax) was 550 cm/s.
Slice thickness was 4.0 mm; and nominal spatial resolution (voxel
size) was 4 mm  0.94 mm  2.1 mm. After that the clinical scan
was completed and additional phase contrast images of a
stationary bottle of water (phantom) were acquired for baseline
ﬂow correction [20]. CMR data were analyzed utilizing Report
Card 4.0 software (GE Medical Systems, Waukesha, WI, USA). Left
ventricle volumes were determined by manual endocardial
border tracing in short axis, from the base to apex in
end-diastolic and end-systolic phases. LV mass was measuredosis jet and imaging slice planes perpendicular to the jet (B).
Table 1
Clinical and cardiac magnetic resonance variables in patients with AS.
Patients (n = 41)
Age (years) 72.7  10.4
Body surface area (m2) 2  0.4
Gender (male) 27
Hypertension 21
Left ventricle ejection fraction (%) 64.1  6.6
Left ventricle end-diastolic volume (ml/m2) 71.9  16.2
Left ventricle end-systolic volume (ml/m2) 26.2  8.6
Left volume stroke volume (ml/m2) 43.9  10.9
Left ventricle cardiac output (ml/min) 5.5  1.3
Left ventricular mass/body surface area (g/m2) 64.9  16.2
Right ventricular ejection fraction (%) 60.7  9.4
Right ventricular end-diastolic volume (ml/m2) 70.8  15.7
Right ventricular end-systolic volume (ml/m2) 28.7  10.8
Aortic valve area (cm2) 1.02  0.23
Phase contrast peak pressure gradient (mmHg) 50.4  23.9
Calculated peak pressure gradient (mmHg) 35.1  23.9
Fig. 2. Relationship between the phase-contrast pressure gradient (PC-PG) and the
calculated pressure gradient (Calc-PG) according to the Pearson’s coefﬁcient (r2
0.577, p < 0.001) (A) and the Bland–Altman analysis (COV 37%; 95% limits of
agreement 17.24–47.78). (B). There is moderate agreement between the 2
parameters.
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epicardial borders in short axis with exclusion of the papillary
muscles. The ejection fraction, stroke volume, and the cardiac
output for both ventricles were derived. Severity of aortic stenosis
was estimated using 3 methods:
- The Calc-PG: inverse Hakki’s formula [15,21], which is a
simpliﬁcation of Gorlin’s [14] formula; DP = (cardiac output/
aortic valve area) [2].
- The aortic valve planimetry. Manual planimetry of the aortic
valve area was measured at systole, when the valve was the most
open. Dark signal was not planimetered as these dark areas likely
represent calcium.
- PC-PG: indirectly calculated by simpliﬁed Bernoulli equation [22]
(DP = 4  velocity2) from the transvalvular aortic jet velocity.
Then, we investigated the correlation between Calc-PG, PC-PG,
and aortic valve area with LV hypertrophy. Two independent
measurements of all parameters were performed in each patient
by two different blinded observers.
All analyses were carried out using a standard statistical
package (SPSS Version 16.0, Chicago, IL, USA and Medcalc
software). Continuous variables were expressed as mean  stan-
standard deviation. Categorical variables were expressed as frequen-
cy and percentage. We compared means of continuous variables
between two groups by using t-test. All tests were 2-tailed, and
statistical signiﬁcance was accepted at p < 0.05. Correlation between
parameters estimating the aortic stenosis severity and LV mass was
calculated by using the coefﬁcient of determination r2. The
comparison between PC-PG and Calc-PG was performed by using
coefﬁcient of determination, the Bland–Altman analysis, and the
receiver operating characteristic (ROC) curve analysis. In the ROC
analysis, we used LV mass as a categorical variable. We performed a
ROC analysis to corroborate our previous results indicating that Calc-
PG correlated better with LV mass than PC-PG and aortic valve area. In
order to perform the ROC analysis we considered LV mass as a
categorical variable. Since deﬁnite and standardized age-, gender-,
and ethnicity-related cut-off values for identifying LV hypertrophy by
CMR in the general population are not available yet we categorized LV
mass by using the 75 percentile of LV mass/body surface area in our
population (70.46 g/m2). LV hypertrophy was considered as a valid
indirect surrogate parameter to estimate the functional severity of
aortic stenosis in ROC analyses [16,17]. Interobserver variability was
measured using the coefﬁcient of determination, Bland–Altman
analysis, and intraclass correlation coefﬁcient analysis. Univariate
and multivariate predictors were analyzed by using bivariate and
multiple linear regression analyses.
Results
Demographic and CMR data of the study population are
summarized in Table 1. Aortic gradient was indirectly calculated
by velocity-encoding phase contrast or it was measured using
Hakki’s formula. There was moderate agreement between the PC-
PG and the Calc-PG according to the coefﬁcient of determination
(r2 0.577, p < 0.001) and as shown in the Bland–Altman analysis
(COV 37%; 95% limits of agreement 17.2–47.8; Fig. 2A and B). We
found that the coefﬁcient of determination of Calc-PG with LV
mass was signiﬁcantly higher (r2 = 0.44, p < 0.001) than the
correlations of PC-PG (r2 = 0.26, p = 0.01) and aortic valve area
with LV mass (r2 = 0.02, p = ns) (Fig. 3). Of note, the correlation
between aortic valve area and LV mass was poor and not
signiﬁcant. After multivariate analysis adjusting for age, gender,
and hypertension, the Calc-PG was conﬁrmed to be the strongest
predictor of increased LV mass (Calc-PG = Beta 0.62, p < 0.001; PC-
PG = Beta 0.47, p < 0.001) (Tables 2A and 2B). In addition, we foundthat Calc-PG shows a higher area under the curve (AUC) (AUC: 0.85,
CI 0.70–0.94, p < 0.0001) when it is associated with the presence of
LV hypertrophy than PC-PG (AUC: 0.74, CI 0.58–0.87, p = 0.03), as
indicated by the ROC curve analysis (Fig. 4). Finally, the Calc-PG
showed the highest interobserver reproducibility in comparison to
Fig. 3. Relationship between left ventricle mass and different parameters to assess aortic stenosis according to the Pearson’s coefﬁcient. (A) There is mild agreement between
phase-contrast pressure gradient (PC-PG) and left ventricular mass (r2 = 0.26, p = 0.01). (B) There is no agreement between aortic valve area and left ventricular mass
(r2 = 0.02, p = ns). (C) There is moderate agreement between calculated pressure gradient (Calc-PG) and left ventricular mass (r2 = 0.44, p < 0.001).
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Table 2A
Multivariate analysis of PC-PG versus left ventricular mass adjusted for age, gender,
and hypertension.
Left ventricular mass (g/m2)
Beta p-value
Age 0.22 ns
Gender 0.36 <0.01
Hypertension 0.01 ns
PC-PG 0.47 <0.001
PC-PG, measured pressure gradient phase contrast sequence.
Table 2B
Multivariate analysis of Calc-PG versus left ventricle mass adjusted for age, gender
and hypertension.
Left ventricular mass (g/m2)
Beta p-value
Age 0.24 0.03
Gender 0.34 <0.01
Hypertension 0.09 ns
Calc-PG 0.62 <0.001
Calc-PG, calculated gradient by cardiac output and aortic valve area.
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(Figs. 5 and 6), whereas the PC-PG had the lowest one. The
interobserver reproducibility according to the coefﬁcient of
determination was: r2 0.515 for aortic valve area measurement,
r2 0.454 for PC-PG and r2 0.608 for Calc-PG (all p < 0.001). The
Bland–Altman analysis showed for the aortic valve area a bias
of 0.10 (COV 13%; 95% limits of agreement 0.23–0.44), for the
PC-PG 18 (COV 46%; 95% limits of agreement 11–47), and for the
Calc-PG 11.4 (COV 35%; 95% limits of agreement from 40.2 to 17.5).
The intraclass correlation coefﬁcient of the interobserver agree-
ment was 0.6901 (95% CI 0.3116–0.8796) for aortic valve area,
0.5263 (95% CI 0.05921–0.8044) for PC-PG, and 0.7375 (95% CI
0.3962–0.8997) for the Calc-PG.
Discussion
Our study demonstrates that in patients with aortic stenosis
assessed by CMR, pressure gradient calculated by the cardiacFig. 4. Receiver operating characteristic curve comparison analysis. Calculated
pressure gradient (Calc-PG) shows a higher area under the curve (AUC) with respect
to the presence of left ventricular hypertrophy (AUC: 0.85, CI 0.70–0.94) than
phase-contrast pressure gradient (PC-PG, AUC: 0.74, CI 0.58–0.87).
Fig. 5. Interobserver reproducibility. Relationship between the aortic valve area
(panel A, r2 0.51, p < 0.001), the phase-contrast pressure gradient (panel B, r2 0.44,
p < 0.001), and the calculated pressure gradient (panel C, r2 0.61, p < 0.001)
obtained from 2 different observers, according to the Pearson’s coefﬁcient. PC-PG,
phase-contrast pressure gradient.
Fig. 6. Interobserver reproducibility. Relationship between the aortic valve area
(panel A, COV 13%; 95% limits of agreement 0.23–0.44), phase-contrast pressure
gradient (PC-PG, panel B; COV 46%; 95% limits of agreement 11.11–46.99), and the
calculated pressure gradient (Calc-PG, panel C; COV 35%; 95% limits of agreement
from 40.17 to 17.45) according to the Bland–Altman analysis.
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gradient measured by using the phase-contrast sequences or the
aortic valve area. Moreover, Calc-PG correlated with the LV
hypertrophy better than the other parameters. LV hypertrophy
represents the main marker of preclinical organ damage in patientswith aortic stenosis. Previous studies indicated that LV hypertro-
phy represents a valid surrogate marker of the severity of the
disease, and remarkably, it is an accurate and strong predictor for
the occurrence of major adverse events, such as systolic and
diastolic dysfunction, heart failure, syncope, and mortality in
subjects affected by aortic stenosis [16,17].
Echocardiography generally provides reliable measurement of
pressure gradient. However, echocardiographic assessment of
transaortic gradient and aortic valve area could be affected by high
thoracic impedance and by the inexperience of the sonographer
[9,10]. CMR allows the direct visualization and planimetry of the
aortic valve area and the ﬂow-dedicated sequences for the
measurement of velocity and pressure gradient. However,
although the evaluation of aortic valve area has been shown to
be accurate and reproducible with this imaging technique
[6–8,11], the measurement of the PC-PG has some limitations
due to no perpendicular sampling of the transaortic ﬂow velocity
with respect to the blood ﬂow, or to aliasing and signal artifacts
caused by turbulences across the aortic valve [6,14,23–25].
Previous studies reported good agreement between PC-PG and
echocardiography [26–28]. However, these studies included
populations with small samples and with mild or moderate
disease. Caruthers et al. [6] measured the correlation between
velocity–time integrals measurements made by CMR and those
made by Doppler ultrasound in 24 patients with aortic stenosis.
They reported a good correlation between CMR and Doppler only
for aortic valve area greater than 0.8 mm2. For values less than
0.8 mm2, PC-PG underestimated more than half of patients with
the disease. O’Brien et al. [23] studied both in vivo and in vitro
aortic stroke volume obtained from the phase contrast sequence in
order to evaluate errors in steady obstructive and non-obstructive
turbulent ﬂows. They concluded that the signal loss correlated
with turbulent ﬂow was associated with ﬂow errors in stenotic jets
for severe lesions. The difﬁculty in measuring turbulent ﬂows by
CMR using the phase contrast sequence could represent a
signiﬁcant limitation to the potential usefulness of this imaging
method in the evaluation of patients with aortic stenosis. In fact,
recent evidence indicates that a correct assessment of transaortic
pressure gradient is necessary to perform an accurate evaluation of
patients with aortic stenosis. First of all, in up to 30% of patients
with aortic stenosis there is a discrepancy between aortic valve
area and pressure gradient in the deﬁnition of the degree of
severity of the valve disease [3,4]. More importantly, the
transaortic pressure gradient was shown to predict the incidence
of adverse outcomes better than aortic valve area in patients with
aortic stenosis [5]. Our study could suggest that an indirect
calculation of the transaortic pressure gradient by using a simple
formula which includes the aortic valve area and cardiac output
could represent an easy and reproducible way to overcome the
limitations of the PC-PG and to more consistently assess the
severity of aortic stenosis. Future studies are needed to validate
these assertions. The Calc-PG does not use phase contrast sequence
that could be a source of error, but only the steady state free
precession sequence. Importantly, Calc-PG is derived from aortic
valve area and cardiac output, and it is known that CMR allows
precise and rapid measurement of aortic valve area and represents
the gold standard for the measurement of cardiac output from
ventricular volumes [28,29]. Because of all these advantages, we
believe that Calc-PG correlates with LV hypertrophy better than
the other parameters. In fact, LV hypertrophy indirectly reﬂects the
actual functional severity of aortic stenosis. Of note, the correlation
between cardiac output and LV mass could also partially
contribute to the close correlation of Calc-PG with LV mass. In
fact, LV mass is strongly dependent on LV chamber size, which is in
turn physiologically determined by stroke volume and myocardial
contractility. Therefore, LV mass is also related to stroke volume
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aortic stenosis with preserved cardiac function, a better preserved
cardiac output could be associated with more developed LV
hypertrophy. In this regard, it is known that in patients with aortic
stenosis and reduced cardiac systolic function, the transaortic
pressure gradient often underestimates the severity of aortic
stenosis [31]. Future studies conducted in subjects with aortic
stenosis and cardiac dysfunction are needed to evaluate how Calc-
PG is correlated with LV hypertrophy and severity of stenosis with
respect to the other parameters.
Of note, we found no correlation between aortic valve area and
LV mass, thus conﬁrming previous evidence indicating a poor
prognostic value of this parameter [32]. Indeed, aortic valve area is
affected by anthropometric characteristics, such as body size, and
it is not infrequent that reductions of valve area are not paralleled
by proportional increases in the pressure gradient in smaller
individuals.
The lack of comparison between Calc-PG and the PC-PG by a
reference standard represents the main limitation of the study.
However, the purpose of our study was to demonstrate that Calc-
PG was a reproducible parameter for transaortic gradient
evaluation and to assess its correlation with LV hypertrophy.
Future studies conducted by using catheterization as a standard
reference are needed to validate this parameter. Interestingly,
PC-PG was previously shown to underestimate the transvalvular
pressure gradient compared to echocardiography [6,23]. Calc-PG
may also estimate lower pressure gradients than echocardiogra-
phy. A direct comparison of Calc-PG to echocardiography with
the reference pressure gradient value obtained with catheteri-
zation will provide more accurate information regarding this
possibility.
Another limitation is the fact that our study is retrospective
with a small number of patients. However, since Calc-PG is
calculated from aortic valve area (a widely validated method to
evaluate aortic stenosis by CMR) and cardiac output (CMR
represents the standard reference to assess LV volume), and since
CMR represents the gold standard for the mass estimation, our
results were consistent and robust and the variability among
different subjects regarding these parameters was relatively low.
This allowed us to observe statistically signiﬁcant results, despite
the limited sample size of our population.
Finally, we included only patients with normal LV ejection
fraction. The correlation between calc-PC and LV hypertrophy in
patients without normal global systolic function may be lower
than what we observed.
In conclusion, our study demonstrates the pressure gradient
calculated by the cardiac output and aortic valve area is easier
and more reproducible than the other commonly used param-
eters to deﬁne the degree of aortic stenosis and it correlates
better with LV mass. Therefore, on the basis of these results, we
propose that this method to calculate the pressure gradient by
CMR could be routinely used in clinical practice to assess the
severity of aortic stenosis together with PC-PG and aortic valve
area.
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